Home > PB Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of TORRENT PHARMACEUTICALS is 17.83.

Share Price ₹4,418.7Jun 05,2026
Market Cap ₹149,528.8 Cr
Book Value₹8,388.4 CrMar2026 - Consolidated Results
Price/Book 17.83xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals

Definition & Calculation of PB (Price/Book ) ratio of TORRENT PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹149,528.8 Cr] as on Jun 05,2026

(/) Book Value [ ₹8,388.4 Cr] based on Mar2026 - Consolidated Results

(=) P/B Ratio [ 17.83x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '17.83 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of TORRENT PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of TORRENT PHARMACEUTICALS


PB Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/b ratio is 17.83x.

- TORRENT PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 12.13x.

- TORRENT PHARMACEUTICALS 's operated at median p/b ratio of 12.84x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/b ratio peaked in Mar2026 at 17.03x.

- TORRENT PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2022 of 7.95x.


How does TORRENT PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
TORRENT PHARMACEUTICALS 8,388.4317.83149,528.8
SUN PHARMACEUTICAL INDUSTRIES LTD83,570.105.12427,933.0
DIVIS LABORATORIES LTD16,761.0010.49175,833.0
CIPLA LTD34,369.403.29113,155.0
DR REDDYS LABORATORIES LTD37,891.502.81106,652.0
MANKIND PHARMA LTD16,300.305.9296,492.8
LUPIN LTD22,448.304.62103,705.0
ZYDUS LIFESCIENCES LTD27,111.404.04109,569.0
AUROBINDO PHARMA LTD37,891.002.2284,151.9
LAURUS LABS LTD5,300.0614.7578,174.1
BIOCON LTD34,031.801.9666,789.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs TORRENT PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 1.96x
Max industry PB 17.83x
Median industry PB 4.62x
Average industry PB 6.64x



You may also like the below Video Courses